The cure rates and survival outcomes for patients with ALL have improved over the past few decades. Today, nearly 90 percent of adults diagnosed with ALL achieve a complete remission, which means that leukemia cells can no longer be seen in the bone marrow with a microscope. Still, despite high remission rates, relapses still commonly occur in adults and survival rates for adult patients remain at approximately 20 to 40 percent. However, these rates can vary significantly, depending on the patient’s ALL subtype and other prognostic factors.
For survival statistics, click here.
Treatment results and outcomes vary among patients. Newer treatment therapies, progress in stem cell transplantation, better supportive care and studies of new drugs in clinical trials are all contributing to improved outcomes and quality of life for people diagnosed with blood cancers.
- Download or order The Leukemia & Lymphoma Society's free booklet, Acute Lymphoblastic Leukemia (ALL) in Adults.